ENDRA Life Sciences (NDRA) Profit After Tax Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Profit After Tax Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 7.60% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -3.37% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.12% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 26.93% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 12.84% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | -26.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55% |
| Dec 31, 2025 | 23.62% |
| Sep 30, 2025 | 32.20% |
| Jun 30, 2025 | 45.01% |
| Mar 31, 2025 | 62.66% |
| Dec 31, 2024 | -184.27% |
| Sep 30, 2024 | 24.08% |
| Jun 30, 2024 | 12.83% |
| Mar 31, 2024 | 5.68% |
| Dec 31, 2023 | 55.63% |
| Sep 30, 2023 | 9.87% |
| Jun 30, 2023 | 28.79% |
| Mar 31, 2023 | -2.96% |
| Dec 31, 2022 | -5.96% |
| Sep 30, 2022 | -29.42% |
| Jun 30, 2022 | -12.25% |
| Mar 31, 2022 | -25.95% |
| Dec 31, 2021 | -37.94% |
| Sep 30, 2021 | 18.41% |
| Jun 30, 2021 | -10.55% |